Artrya (ASX:AYA) secured a three-year commercial agreement with Sonic Healthcare's (ASX:SHL) radiology division for the use of Salix Coronary Anatomy platform for coronary artery disease assessment at the point of care, according to a Wednesday Australian bourse filing.
The contract will generate revenue through a software-as-a-service subscription model and the first revenue is expected in the fiscal fourth quarter, the filing said.
Salix will be integrated into all Sonic Healthcare radiology centers that perform coronary computed tomography angiography scans for coronary heart disease detection, per the filing.